Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
Clinical trial NCT07106034 · RECRUITING
Trial details
- NCT number
- NCT07106034
- Sponsor
- Shanghai Pudong Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-31
- Primary completion
- 2027-07-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.